Dosage form
Lyophilisate for preparation of solution for the on/m introduction in the form of powder or porous mass of white or white with a yellowish sheen color.
Composition
1 FL.

complex water-soluble polypeptide fractions with molecular weight more than 10,000 Da (Cortexin) 10 mg

Excipients: glycine, 12 mg (stabilizer).

When using the drug for indications side effects are not detected. Theoretically possible individual hypersensitivity to the drug.


Testimony
In the complex therapy of the following conditions and diseases:

— violations of cerebral circulation and their consequences;

— traumatic brain injury and its consequences;

— encephalopathy of various Genesis;

cognitive disorders (disorders of memory and thinking);

— acute and chronic encephalitis and encephalomyelitis;

— epilepsy;

— asthenic conditions;

— suprasegmental autonomic disorders;

— reduced ability to learn;

— delay of psychomotor and speech development in children;

critical condition in newborns with perinatal lesions of the nervous system;

— various forms of cerebral palsy
Contraindications
— individual intolerance of the drug.

Application of pregnancy and breastfeeding

The drug is contraindicated during pregnancy (because of the lack of clinical trial data).

If necessary, the appointment of the drug during lactation should stop breastfeeding (due to lack of clinical trial data).
Drug interactions
Drug interactions drug Cortexin® not described.